Why Skills-First Leadership Is Replacing the Ivy League Playbook in the C-Suite
05/23/2025
No Comments
The old prestige pyramid—where Ivy League degrees and blue-chip consulting backgrounds paved the way to the CEO seat—is cracking.
December 3, 2021: -On Thursday, European stocks pulled back as concerns persisted over the omicron Covid variant. The pan-European Stoxx 600 decreased 1.2% in early trade, with tech stocks shedding 2.6% to lead losses as all sectors and major bourses slid well into the red.
Major markets across Asia-Pacific and the U.S. had bounced back on Wednesday despite the fears about the variant and the Federal Reserve mulling a quicker-than-planned taper.
But global stocks appear to struggle to regain momentum amid continuing uncertainty near the risks posed by the new omicron Covid variant, first spotted in South Africa in the previous week and designated a “variant of concern” by the World Health Organization.
On Wednesday, the WHO said that at least 23 countries from five of six WHO regions have reported cases of omicron, “and we expect that number to grow.” It also said that hospitalizations are rising across South Africa but that it’s still too early to know if the omicron variant is increasing severe Covid-19 cases.
On Thursday, Asia-Pacific markets were mixed while U.S. stock index futures pointed to a higher open, after selling off on Wednesday as the CDC confirms the first case of the omicron variant in the U.S. The first case of the highly mutated variant was detected in northern California.
Data released on Thursday include the eurozone unemployment rate for October and producer prices for the same month.
At the top of the Stoxx 600, Vifor Pharma shares are increasing over 12% deals on reports that Australian biotech giant CSL is in talks to buy the Swiss group for nearly $10 billion.
At the bottom of the European blue-chip index, Britain’s Royal Mail fell more than 6%.
The old prestige pyramid—where Ivy League degrees and blue-chip consulting backgrounds paved the way to the CEO seat—is cracking.
Loud leaders once ruled the boardroom. Charisma was currency. Big talk drove big valuations.
But the CEOs who make history in downturns aren’t the ones with the deepest cuts
Companies invest millions in leadership development, yet many of their best executives leave within a few years. Why?
The most successful business leaders don’t just identify gaps in the market; they anticipate future needs before anyone else.
With technological advancements, shifting consumer expectations, and global interconnectedness, the role of business leaders
Maushum Basu is a visionary leader who inspires his team with a clear, compelling purpose. Unafraid to take calculated risks, he understands that growth often stems from change and innovation. His deep commitment to both Airia Brands, Inc.
When speaking with Martin Paquette, one thing is immediately apparent: he’s honest. His transparency is refreshing. While many shy away from such vulnerability, Paquette sees it as a force to reckon with. The incredible emotional intelligence speaks to years of looking within—it’s also what allows him to acknowledge his mistakes gracefully and use them as opportunities to innovate.
Marina Charriere, CEO of Star Drug Testing Services, Star Drug Testing Services (Windsor Park), and First Defence Face Masks go hand in hand. Star is a drug and alcohol testing facility, and First D F M is a face mask company.
Lejjy Gafour, CEO, CULT Food Science Corp. Lejjy is a self-taught entrepreneur and experienced company operator who made his start creating opportunities at the young age of 14, and he has been working, leading, and building businesses ever since.
Leave us a message
Subscribe
Fill the form our team will contact you
Advertise with us
Fill the form our team will contact you
